Metabian is a European pharmaceutical company and a marketing authorisation holder in Europe, with addresses strategically located in France, Spain, and Romania. Focused on addressing critical healthcare needs, Metabian specialises in the acquisition and commercialisation of European-manufactured generic medicines across a diverse range of therapeutic areas. The company’s portfolio is designed to target pressing medical conditions, with a strong emphasis on women’s health, anti-infective treatments, pain management, cardiovascular health, metabolic disorders, and central nervous system diseases. Metabian ensures that its products meet the highest standards of safety and efficacy developed and manufactured exclusively in Europe, serving international markets. With a commitment to innovation and affordability, The Company plays a crucial role in improving patient access to essential medications while fostering sustainable growth in the generic pharmaceutical industry. Its presence in key European locations positions the company to respond effectively to international healthcare demands and regulatory landscapes, driving its mission of advancing health outcomes globally.